checkAd

     121  0 Kommentare Zomedica to Develop Gastrointestinal Testing Panel for TRUFORMA - Seite 3

    The forward-looking information contained in this news release is expressly qualified by this cautionary statement. We undertake no duty to update any of the forward-looking information to conform such information to actual results or to changes in our expectations except as otherwise required by applicable securities legislation. Readers are cautioned not to place undue reliance on forward-looking information.

    Investor Relations Contact:
    PCG Advisory Group
    Kirin Smith, COO
    ksmith@pcgadvisory.com
    +1 646.863.6519
    www.pcgadvisory.com

    Media Contact:
    Meredith Newman
    mnewman@zomedica.com
    +1 734.369.2555 ext. 119


    Seite 3 von 3




    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Zomedica to Develop Gastrointestinal Testing Panel for TRUFORMA - Seite 3 Three new assays to be added to the five assays currently under developmentANN ARBOR, Mich., Sept. 08, 2020 (GLOBE NEWSWIRE) - Zomedica Pharmaceuticals Corp. (NYSE American:  ZOM) announced today that it has agreed with its development partner …

    Schreibe Deinen Kommentar

    Disclaimer